Clinical trial
A Long-term Follow-up of Adult Kidney and Liver Allograft Recipients Previously Enrolled Into a Tacrolimus (Advagraf) Trial. A Multicentre Non-interventional Post Authorization Study (PAS)
NCT02057484 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-term Follow-up of Adult Kidney and Liver Allograft Recipients Previously Enrolled Into a Tacrolimus (Advagraf) Trial. A Multicentre Non-interventional Post Authorization Study (PAS)
- Lead sponsor
- Astellas Pharma Europe Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 3, 2014
- Completion date
- October 17, 2017
- Enrollment
- 2,300 (actual)
- Sites
- 145
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplant, liver transplant